Xie, Xuping http://orcid.org/0000-0003-0918-016X
Liu, Yang
Liu, Jianying
Zhang, Xianwen
Zou, Jing
Fontes-Garfias, Camila R. http://orcid.org/0000-0002-1912-8413
Xia, Hongjie http://orcid.org/0000-0002-2520-7038
Swanson, Kena A.
Cutler, Mark
Cooper, David
Menachery, Vineet D.
Weaver, Scott C. http://orcid.org/0000-0001-8016-8556
Dormitzer, Philip R. http://orcid.org/0000-0003-0671-6360
Shi, Pei-Yong http://orcid.org/0000-0001-5553-1616
Funding for this research was provided by:
Foundation for the National Institutes of Health (AI42759)
Article History
Received: 8 January 2021
Accepted: 28 January 2021
First Online: 8 February 2021
Competing interests
: The authors declare competing interests. X.X., V.D.M. and P.-Y.S. have filed a patent on the reverse genetic system. K.A.S., M.C., D.C. and P.R.D. are employees of Pfizer and might hold stock options. X.X., J.Z., C.R.F.G., H.X. and P.-Y.S. received compensation from Pfizer to perform the neutralization assay.
Free to read: This content has been made available to all.